2018-004231-72: Randomized study of the detection of mutations by BEAMing technology in advance of the radiological diagnosis of progression in patients with metastatic colorectal cancer and primary tumor in the left colon / rectum Estudio aleatorizado de la detección de mutaciones por tecnología BEAMing de forma anticipada al diagnóstico radiológico de la progresión en pacientes con cáncer colorrectal metastásico y tumor primario en el colon izquierdo/recto |
|
|
| Ongoing | 4 | 80 | Europe | Calcium Folinate, cetuximab, Hidrocloruro de irinotecán trihidrato, Oxaliplatino, panitumumab, L01XC06, , Solution for solution for injection, Solution for infusion, 5-Fluorouracilo, Calcium Folinate, Erbitux, Irinotecán, Oxaliplatino Teva, Vectibix | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), Oncology Department | Median of the progression-free survival of patients with mCRC who maintains the treatment in conventional 1st line, QT + anti-EFGR, versus patients who withdraw anti-EGFR therapy after detection of mutations of the RAS gene / BRAF through the OncoBEAM ™ test. Comparar la mediana de supervivencia libre de progresión de pacientes con CCRm que mantienen el tratamiento en 1º línea convencional, QT + anti-EFGR, frente a la de los pacientes a los que se retira la terapia anti-EGFR tras la detección de mutaciones del gen RAS/BRAF mediante el test OncoBEAM™., Patients with colon-rectal cancer, primary tumor in left / rectum colon. Pacientes con Cáncer colo-rectal, tumor primario en colon izquierdo/recto., Diseases [C] - Cancer [C04] | | | | |
2020-002533-14: Targeted therapy for advanced colorectal cancer patients. Terapia mirata per il trattamento dei pazienti con carcinoma metastatico del colon-retto. |
|
|
| Ongoing | 4 | 106 | Europe | Oxaliplatino, Irinotecan, Cetuximab, Panitumumab, Capecitabina, Bevacizumab, Fluorouracile, Calcio Folinato, ZALTRAP, [L01XA 03], [L01XX19], [L01XC06], [L01XC08], [L01BC06], [L01XC07], [L01BC02], [V03AF03], [L01XX44], Concentrate and solvent for concentrate for solution for infusion, Concentrate for solution for injection/infusion, Solution for injection/infusion, Film-coated tablet, Concentrate for solution for infusion, Powder for solution for injection | DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA, Unione Europea, Horizon 2020 | unresectable metastatic colorectal cancer (mCRC) carcinoma del colon-retto metastatico (mCRC) non operabile, colorectal cancer Tumore del colon- retto, Diseases [C] - Cancer [C04] | | | | |